Literature DB >> 7909396

Neuropharmacology of anxiety: perspectives and prospects.

M Hamon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909396     DOI： 10.1016/0165-6147(94)90104-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  5 in total

1.  Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion.

Authors:  M Masugi; M Yokoi; R Shigemoto; K Muguruma; Y Watanabe; G Sansig; H van der Putten; S Nakanishi
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

2.  High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice.

Authors:  Juliane Zemdegs; Gaël Quesseveur; David Jarriault; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  Br J Pharmacol       Date:  2015-12-09       Impact factor: 8.739

3.  Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.

Authors:  A Siniscalchi; D Rodi; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.

Authors:  F Hernando; J A Fuentes; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

5.  BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.

Authors:  G Quesseveur; D J David; M C Gaillard; P Pla; M V Wu; H T Nguyen; V Nicolas; G Auregan; I David; A Dranovsky; P Hantraye; R Hen; A M Gardier; N Déglon; B P Guiard
Journal:  Transl Psychiatry       Date:  2013-04-30       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.